Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 SEK | -11.37% | -5.67% | +196.14% |
07/05 | Transcript : Ascelia Pharma AB - Special Call | |
02/05 | Ascelia Pharma AB Successfully Meets Primary Endpoint with Strong Headline Results in Orvigance Phase 3 Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+196.14% | 31.16M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+47.07% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- ACE Stock
- News Ascelia Pharma AB
- Transcript : Ascelia Pharma AB, Q1 2023 Earnings Call, May 11, 2023